Group 1: Financial Performance - The company achieved a revenue of 533 million yuan in 2024, with a net profit of 53.02 million yuan attributed to shareholders [6] - The sales gross margin increased from 22.77% in Q1 2023 to 52.75% in Q1 2025, driven by growth in the lithium extraction segment and new product sales [2] Group 2: Investment and Growth Strategy - The company plans to focus on the development and innovation of separation materials and technologies, aiming to become a leader in the membrane separation industry [3] - Future investments will be directed towards mergers and acquisitions to promote business development and enhance shareholder returns [3] Group 3: Market Expansion and Competitive Advantage - The company aims to expand its overseas market presence by establishing offices and partnerships, leveraging its high-performance membrane materials and cost control capabilities [3] - The competitive advantages in the water treatment sector include significant R&D capabilities and project implementation expertise [7] Group 4: Research and Development - In 2024, the company invested 56.23 million yuan in R&D, accounting for 10.54% of its revenue, with a focus on optimizing its R&D system [9] - The fourth-generation lithium adsorption agent has improved adsorption capacity by 30%-50% compared to previous generations, enhancing lithium extraction efficiency and reducing costs [11] Group 5: Environmental and Regulatory Compliance - The company is committed to upgrading its technology to meet increasingly stringent environmental standards in water treatment [13] - The membrane integration technology solutions are tailored to meet specific industry requirements, ensuring compliance with production processes [12]

Group 1 - The company raised a total of RMB 254.12 million from its initial public offering (IPO) by issuing 43,438,600 shares at a price of RMB 5.85 per share, with a net amount of RMB 202.80 million after deducting issuance costs of RMB 51.31 million [1] - As of December 31, 2024, the company has used RMB 204.23 million of the raised funds, with no funds used in the year 2024, resulting in a balance of RMB 0 in the fundraising account [2][4] - The company has completed all fundraising investment projects and closed the fundraising special account, transferring a remaining balance of RMB 0.27 million to its own account for working capital [2][3] Group 2 - The company has established a fundraising management system to ensure compliance with regulations and protect investor interests, implementing special account management for the raised funds [3] - There were no instances of using idle raised funds for temporary working capital or cash management in the year [6] - The company did not change any fundraising investment projects during the reporting period [6] Group 3 - The company achieved operating revenue of RMB 375.24 million in the reporting period, a decrease of 2.34% compared to the previous year, and a net profit attributable to shareholders of RMB 38.59 million, down 16.00% year-on-year [45] - The company is a high-tech enterprise specializing in the research and production of high-performance membrane materials and related equipment, with products including reverse osmosis membranes and composite pressure vessels [32][33] - The membrane separation technology industry is characterized by high technical barriers and is experiencing rapid growth, with increasing applications in various sectors such as water treatment and food processing [38][39]